YCM
BIOSU

Yakira Capital Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Yakira Capital Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,000
Closed -$999K – 484
2022
Q1 		$999K Hold
100,000
– – 0.14% 192
2021
Q4 		$1M Buy
+100,000
New +$1M 0.13% 185

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.97% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.5% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Yakira Capital Management's BIOSU Position: Q2 2022 in Review

Yakira Capital Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2022, closing a stake of 100,000 shares — an estimated $999K sold.

Yakira Capital Management first reported a position in BIOSU in Q4 2021 and held it in 2 quarters. The position peaked at $1M in Q4 2021. 24 funds tracked by Wall St. Rank hold BIOSU as of Q2 2022.

  • Yakira Capital Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • Yakira Capital Management sold 100,000 BioPlus Acquisition Corp. Unit shares in Q2 2022, an estimated $999K.
  • Yakira Capital Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Yakira Capital Management's BioPlus Acquisition Corp. Unit position peaked at $1M in Q4 2021.
  • 24 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2022.

Based on Yakira Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.